Screening of protein biomarkers for sports doping and veterinary control

[1]  Irene van den Broek,et al.  Current trends in mass spectrometry of peptides and proteins: Application to veterinary and sports-doping control. , 2015, Mass spectrometry reviews.

[2]  P. Sönksen,et al.  Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes. , 2013, Drug testing and analysis.

[3]  M. Nielen,et al.  Potential of treatment-specific protein biomarker profiles for detection of hormone abuse in cattle. , 2013, Journal of agricultural and food chemistry.

[4]  Shahram Mohaghegh,et al.  Doping and the Latest Prohibited List of the World Anti-Doping Agency (WADA) , 2013 .

[5]  Terry F. McGrath,et al.  Effect-based proteomic detection of growth promoter abuse , 2013, Analytical and Bioanalytical Chemistry.

[6]  M. Nielen,et al.  Multiple Protein Biomarker Assessment for Recombinant Bovine Somatotropin (rbST) Abuse in Cattle , 2012, PloS one.

[7]  M. Nielen,et al.  Monitoring milk for antibodies against recombinant bovine somatotropin using a microsphere immunoassay-based biomarker approach , 2012 .

[8]  G. Baumann.  Growth hormone doping in sports: a critical review of use and detection strategies. , 2012, Endocrine reviews.

[9]  M. Meyer,et al.  Current applications of high-resolution mass spectrometry in drug metabolism studies , 2012, Analytical and Bioanalytical Chemistry.

[10]  C. Reichel.  OMICS-strategies and methods in the fight against doping. , 2011, Forensic science international.

[11]  F. Pontén,et al.  The Human Protein Atlas as a proteomic resource for biomarker discovery , 2011, Journal of internal medicine.

[12]  J. Kopchick,et al.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects , 2011, Proteomics.

[13]  F. Guadagni,et al.  "Proteomineering" or not? The debate on biomarker discovery in sera continues. , 2011, Journal of proteomics.

[14]  Morten Krogh,et al.  Protein expression changes in skeletal muscle in response to growth promoter abuse in beef cattle. , 2011, Journal of proteome research.

[15]  Shu-juan Guo,et al.  Protein microarrays for systems biology , 2011, Acta biochimica et biophysica Sinica.

[16]  S. Mosler,et al.  Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR , 2010, Molecular and Cellular Endocrinology.

[17]  B. Le Bizec,et al.  Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle , 2010 .

[18]  K. Langohr,et al.  Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples. , 2010, Journal of pharmaceutical and biomedical analysis.

[19]  Ariadni Vonaparti,et al.  Screening in veterinary drug analysis and sports doping control based on full-scan, accurate-mass spectrometry , 2010 .

[20]  S. Kageyama,et al.  Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.

[21]  B. Le Bizec,et al.  Detection of recombinant bovine somatotropin in milk and effect of industrial processes on its stability. , 2010, Analytica chimica acta.

[22]  S. Bornstein,et al.  Pilot Study of Serum Inhibin B as a Potential Marker of Testosterone Doping in Weight Lifting Men , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[23]  Pingbo Zhang,et al.  Multiplex assays for biomarker research and clinical application: Translational science coming of age , 2010, Proteomics. Clinical applications.

[24]  M. Baker,et al.  High‐abundance protein depletion: Comparison of methods for human plasma biomarker discovery , 2010, Electrophoresis.

[25]  B. Le Bizec,et al.  Identification of cows treated with recombinant bovine somatotropin. , 2010, Journal of agricultural and food chemistry.

[26]  M. Mascini,et al.  Surface plasmon resonance imaging for affinity-based biosensors. , 2010, Biosensors & bioelectronics.

[27]  L. Frohman,et al.  Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[28]  M. Pfaffl,et al.  The use of omic technologies for biomarker development to trace functions of anabolic agents. , 2009, Journal of chromatography. A.

[29]  G. Ball,et al.  High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. , 2009, Rapid communications in mass spectrometry : RCM.

[30]  T. Etherton.  ASAS centennial paper: animal growth and development research: historical perspectives. , 2009, Journal of animal science.

[31]  Osquel Barroso,et al.  Detection of GH abuse in sport: Past, present and future. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[32]  S. Harridge,et al.  IGF-I and GH: potential use in gene doping. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[33]  R. Kay,et al.  Multiplexed LC‐MS/MS analysis of horse plasma proteins to study doping in sport , 2009, Proteomics.

[34]  R. Ventura,et al.  Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes. , 2009, Journal of pharmaceutical and biomedical analysis.

[35]  Mai M H Mansour,et al.  Gene doping: of mice and men. , 2009, Clinical biochemistry.

[36]  B. Le Bizec,et al.  Elimination kinetic of recombinant somatotropin in bovine. , 2009, Analytica chimica acta.

[37]  Philippe Delahaut,et al.  Effect of growth-promoting 17beta-estradiol, 19-nortestosterone and dexamethasone on circulating levels of nine potential biomarker candidates in veal calves. , 2009, Analytica chimica acta.

[38]  C. Elliott,et al.  Feasibility of a clinical chemical analysis approach to predict misuse of growth promoting hormones in cattle. , 2009, Analytical chemistry.

[39]  R. Baxter,et al.  Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. , 2008, The Journal of clinical endocrinology and metabolism.

[40]  P. Sönksen,et al.  Growth hormone, IGF‐I and insulin and their abuse in sport , 2008, British journal of pharmacology.

[41]  P. Tuite,et al.  ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand , 2008, Journal of Immunological Methods.

[42]  M. Bollen,et al.  Testing for recombinant erythropoietin , 2008, American journal of hematology.

[43]  B. Le Bizec,et al.  Detection of secondary biomarker of met-eGH as a strategy to screen for somatotropin misuse in horseracing. , 2008, The Analyst.

[44]  M. Nielen,et al.  A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists , 2007, Analytical and bioanalytical chemistry.

[45]  A. Scaloni,et al.  Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: urine and plasma kinetic profile and changes in plasma protein expression , 2007, Proteomics.

[46]  M. Thevis,et al.  Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. , 2007, Analytical chemistry.

[47]  L. Frohman,et al.  Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. , 2006, The Journal of clinical endocrinology and metabolism.

[48]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[49]  K. McKeever,et al.  Low dose exogenous erythropoietin elicits an ergogenic effect in standardbred horses. , 2006, Equine veterinary journal. Supplement.

[50]  A. Urbani,et al.  Proteomic investigation in the detection of the illicit treatment of calves with growth‐promoting agents , 2006, Proteomics.

[51]  Michael Buckley,et al.  Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry. , 2006, The Journal of clinical endocrinology and metabolism.

[52]  G. T. Schelling,et al.  Bovine growth hormone treatment increased IGF-I in circulation and induced the production of a specific immune response in rainbow trout (Oncorhynchus mykiss) , 2005 .

[53]  R. Devlin,et al.  Transgenic salmon overexpressing growth hormone exhibit decreased myostatin transcript and protein expression , 2004, Journal of Experimental Biology.

[54]  J. Kratzsch,et al.  Potential parameters for the detection of hGH doping , 2003, Analytical and bioanalytical chemistry.

[55]  D. Gerrard,et al.  Administration of recombinant porcine somatotropin (rpST) changes hormone and metabolic status during early pregnancy. , 2002, Domestic animal endocrinology.

[56]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[57]  T. Yada,et al.  Recombinant bovine growth hormone treatment of tilapia: growth response, metabolic clearance, receptor binding and immunoglobulin production , 2002 .

[58]  J. Kopchick,et al.  Biological effects of growth hormone and its antagonist. , 2001, Trends in molecular medicine.

[59]  S. Arver,et al.  Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. de la Torre,et al.  Screening procedure for beta-adrenergic drugs in sports drug testing by immunological methods. , 1998, Journal of analytical toxicology.

[61]  J. Powrie,et al.  Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH , 1997, Clinical endocrinology.

[62]  F. Monteau,et al.  Analytical strategies to detect use of recombinant bovine somatotropin in food-producing animals , 2014 .

[63]  R. Westermeier,et al.  Difference Gel Electrophoresis (DIGE) , 2012, Methods in Molecular Biology.

[64]  Katrin Marcus,et al.  Quantitative Methods in Proteomics , 2012, Methods in Molecular Biology.

[65]  Henning Urlaub,et al.  Quantitative Mass Spectrometry-Based Proteomics: An Overview , 2012, Quantitative Methods in Proteomics.

[66]  P. Hoffmann,et al.  Comparative 2D DIGE analysis of the depleted serum proteome for biomarker discovery. , 2012, Methods in molecular biology.

[67]  R. Holt,et al.  Detecting growth hormone abuse in athletes , 2011, Analytical and bioanalytical chemistry.

[68]  C. Lundby,et al.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach. , 2011, Journal of applied physiology.

[69]  D. Russell,et al.  Glycoprotein microarray for the fluorescence detection of antibodies produced as a result of erythropoietin (EPO) abuse , 2010 .

[70]  Y. Mechref,et al.  Glycoprotein enrichment through lectin affinity techniques. , 2008, Methods in molecular biology.

[71]  J. Veldhuis,et al.  The Role of Growth Hormone Secretagogues and Ghrelin in Feeding and Body Composition , 2007 .

[72]  P. Sönksen,et al.  Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. , 2000, The Journal of clinical endocrinology and metabolism.

[73]  C J Gore,et al.  A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. , 2000, Haematologica.

[74]  G. Palomaki,et al.  Reference distributions for the negative acute‐phase serum proteins, albumin, transferrin and transthyretin: A practical, simple and clinically relevant approach in a large cohort , 1999, Journal of clinical laboratory analysis.